Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Petros Pharmaceuticals Inc (PTPI)

NASDAQ
Currency in USD
Disclaimer
0.641
-0.004(-0.62%)
Closed
After Hours
0.660+0.019(+2.964%)

PTPI Comments

Ideally, it seems to me, open here for $2.20 and wait for a quick run north.
Whats an entry point?
First target is 12$
300% today 🔥 watch out
Huge news coming. Load up. Called DTST weeks before the news happened. Dont miss this double.
going to the moon
vivo volum!
Vivo now?
Finally sold with a little bit of profits. Au revoir.
Worst stock I have ever bought
i hope you still own it.....
Should have sold at pre market, lol.
Pump and dump
This is horrible
buying more
Will you add more
After the blood from today
Man there are many pump and dumps but the news actually really good maybe I hold this time
427% YTD growth and marketing agreement. It will shoot
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.